MilliporeSigma, Merck KGaA’s life science service provider, is teaming with the University of Oxford’s vaccine-focused research body, the Jenner Institute, to develop more cost-effective vaccine ...
AUSTIN, Texas, Dec. 13 /PRNewswire-FirstCall/ -- Introgen Therapeutics, Inc. (Nasdaq: INGN) announced today that it has been granted a broad patent by the European ...
HELSINKI, Finland, Jan. 11, 2023 (GLOBE NEWSWIRE) -- Valo Therapeutics Oy (ValoTx), the developer of novel, adaptable immunotherapy platforms for cancer and infectious diseases, today announced it has ...
OXGENE describes how self-silencing adenoviral vectors can deliver high-quality, high-titer AAV and even grow AAV from AAV Until very recently, adeno-associated virus (AAV) had an excellent safety ...
Adenoviral vectors will transduce a wide range of target cells resulting in high-level gene expression. They are non-integrating vectors so expression in dividing cells is progressively lost. First ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results